In-Space Manufacturing: Building Products in Zero Gravity

What if the next breakthrough in fiber optics, pharmaceuticals, or semiconductor manufacturing doesn't come from a factory on Earth — but from a factory in orbit? In-space manufacturing (ISM) leverages the unique environment of microgravity to produce materials and products that are impossible or prohibitively difficult to make under the influence of gravity.

This isn't science fiction. Companies are already producing experimental materials on the International Space Station, and a new generation of startups is designing dedicated orbital manufacturing platforms for the post-ISS era. The in-space manufacturing market is projected to grow from a few hundred million dollars today to $10+ billion by 2035, driven by advances in automated manufacturing, commercial space stations, and falling launch costs.

Why Microgravity Matters for Manufacturing

Gravity is so pervasive on Earth that we rarely consider its effects on manufacturing processes. But gravity causes several phenomena that limit material quality and manufacturing precision:

• Convection: In a gravitational field, hot fluids rise and cold fluids sink, creating convection currents that disrupt crystal growth, alloy mixing, and chemical processes. In microgravity, convection is essentially eliminated
• Sedimentation: Heavy particles sink and light particles float, causing separation in mixtures. Microgravity enables perfectly homogeneous mixing of materials with different densities
• Container effects: On Earth, molten materials must be held in containers, which can contaminate the product through contact. In microgravity, materials can be processed while floating freely using containerless processing — held in place by electromagnetic or acoustic forces
• Surface tension dominance: Without gravity, surface tension becomes the dominant force shaping liquids, enabling perfect spheres and ultra-uniform coatings
• Hydrostatic pressure: Gravity creates pressure gradients in fluids and biological systems. Removing this pressure changes how cells grow, crystals form, and materials solidify

ZBLAN Fiber Optics: The First Killer App

The most commercially advanced in-space manufacturing application is ZBLAN optical fiber — a fluoride glass fiber that could be 10-100x better than conventional silica fiber for certain wavelengths.

On Earth, ZBLAN fiber production is plagued by microcrystalline defects caused by gravity-driven convection during the cooling process. These crystals scatter light, limiting fiber performance. In microgravity, the absence of convection allows ZBLAN to cool more uniformly, producing fiber with dramatically fewer defects and lower signal loss.

Several companies are pursuing space-based ZBLAN production:

• FOMS Inc. (Fiber Optic Manufacturing in Space): Has produced ZBLAN fiber samples on the ISS demonstrating improved quality
• Flawless Photonics: Developing an automated fiber-drawing system designed for orbital deployment, with ISS experiments demonstrating 100x improvement in attenuation
• Physical Optics Corporation: Produced ZBLAN fiber on Blue Origin suborbital flights to study the effects of brief microgravity exposure

Space-produced ZBLAN fiber could be worth $1-5 million per kilogram — making it one of the few products where the value-to-mass ratio justifies the cost of manufacturing in orbit and returning to Earth.

Bioprinting and Tissue Engineering

One of the most promising in-space manufacturing applications is 3D bioprinting — printing living tissue structures using bioinks containing living cells. On Earth, gravity causes soft tissue structures to collapse under their own weight during the printing and maturation process, limiting the complexity of structures that can be created. In microgravity, bioprinted structures maintain their shape, enabling:

• Organ scaffolds: 3D-printed tissue structures for transplant organs (hearts, kidneys, livers) that require complex internal vasculature impossible to maintain against gravity during printing
• Cartilage and bone: Orthopedic implants with optimized internal structures
• Drug testing tissues: Human tissue models for pharmaceutical testing, potentially reducing the need for animal trials

Redwire's BioFabrication Facility (BFF) on the ISS has successfully printed human tissue constructs, including meniscus knee cartilage. The company is developing commercial bioprinting capabilities for the post-ISS era. Other players include Techshot (now part of Redwire) and 3D BioFiber.

Protein Crystal Growth

Protein crystallography — growing crystals of biological proteins to determine their 3D structure — is critical for drug discovery. On Earth, gravity-driven convection disrupts crystal growth, producing smaller, less ordered crystals. In microgravity, protein crystals grow larger, more uniform, and with fewer defects, enabling higher-resolution structural determination.

Pharmaceutical companies including Merck, Eli Lilly, and Bristol-Myers Squibb have conducted protein crystallization experiments on the ISS. Merck's microgravity research on the drug Keytruda (pembrolizumab) led to a new formulation that can be administered via injection rather than IV infusion — a direct commercial outcome from space-based R&D worth billions in market value.

Semiconductor and Crystal Growth

Microgravity offers advantages for growing semiconductor crystals and exotic materials:

• Bulk crystal growth: Silicon, gallium arsenide, and other semiconductor crystals grown in microgravity can have fewer defects and more uniform properties. While terrestrial crystal growth has become very refined, space-grown crystals could serve niche applications requiring extreme purity
• Exotic alloys: Combining metals with very different densities (which separate under gravity) can produce novel alloys with unique properties — such as high-strength, lightweight structural materials
• Metamaterials: Precise 3D manufacturing of metamaterials with properties not found in nature (negative refractive index, programmable stiffness) may be enabled by microgravity processing

Commercial Manufacturing Platforms

The ISS has been the primary platform for in-space manufacturing research, but it was designed as a research laboratory, not a production facility. As the ISS approaches retirement (currently planned for 2030), several companies are developing dedicated commercial platforms:

Varda Space Industries

Varda is building autonomous orbital factories — spacecraft that launch, manufacture products in microgravity, and return them to Earth in reentry capsules. Varda's first mission in 2023 successfully manufactured pharmaceutical crystals in orbit and returned them to Earth, demonstrating the end-to-end concept. The company is scaling toward regular production missions, initially focused on pharmaceutical manufacturing.

Space Forge

UK-based Space Forge is developing a reusable satellite platform for in-space manufacturing, with a focus on advanced semiconductor materials. Their ForgeStar vehicle is designed for repeated missions, launching to orbit, manufacturing in microgravity, and returning to Earth for refurbishment.

Commercial Space Stations

The next generation of commercial space stations — Vast Haven-1, Axiom Station, Sierra Space's Orbital Reef (with Blue Origin) — will include dedicated manufacturing modules. These stations will provide larger volumes, more power, and purpose-built manufacturing equipment compared to the ISS.

3D Printing and In-Space Construction

Beyond manufacturing products for return to Earth, in-space manufacturing also encompasses building structures in orbit:

• Redwire's Archinaut: A robotic system for manufacturing and assembling large structures in space, including solar arrays and antenna reflectors too large to fit in a rocket fairing
• Made In Space (Redwire): Has operated 3D printers on the ISS since 2014, producing tools, spare parts, and experimental structures. Demonstrated that astronauts can manufacture replacement parts on demand rather than waiting for resupply missions
• Lunar and Mars construction: NASA and ESA are developing 3D printing technology for building habitats on the Moon and Mars using local regolith (soil), reducing the mass that must be launched from Earth

The Economics of Space Manufacturing

The fundamental challenge for in-space manufacturing is the cost equation: manufacturing in orbit currently costs orders of magnitude more than manufacturing on Earth. The business case depends on products where:

1. Value-to-mass ratio is extremely high: Products worth $100,000+ per kilogram can justify launch and return costs
2. Microgravity quality improvement is significant: The space-manufactured product must be meaningfully superior to the terrestrial equivalent
3. No terrestrial alternative exists: Some products may be literally impossible to make on Earth, creating a manufacturing monopoly for space

Current launch costs to LEO are approximately $2,500-$5,000 per kg (SpaceX Falcon 9), with Starship expected to drive this below $500/kg. Return-to-Earth costs add another $5,000-$50,000/kg depending on the reentry vehicle. At these prices, products worth more than ~$100,000/kg begin to make economic sense for space manufacturing.

Products that currently meet this threshold include:

• ZBLAN fiber: $1-5M/kg
• Pharmaceutical crystals: $100K-$10M/kg for high-value biologics
• Bioprinted organs: Potentially $100K-$1M each (a human kidney transplant costs $400K+)
• Specialty semiconductors: $50K-$500K/kg for exotic materials

Challenges and Barriers

• Automation: Human labor in space is prohibitively expensive ($50,000+/hour for astronaut time). Manufacturing processes must be highly automated, which requires significant R&D investment
• Quality control: Inspecting and quality-testing products in orbit is more difficult than on Earth. Remote sensing, automated inspection, and AI-based quality systems are essential
• Return logistics: Getting products safely back to Earth requires reentry vehicles with precise landing capability. Companies like Varda and Space Forge are developing dedicated return capsules
• Regulatory framework: Manufacturing drugs, medical devices, or food in space raises novel regulatory questions for FDA, EMA, and other agencies
• Scale: Current ISM is at experimental/pilot scale. Achieving production volumes that matter commercially requires dedicated manufacturing platforms with consistent access

The Future of Space Manufacturing

In-space manufacturing is following the classic technology adoption curve: early R&D on the ISS (2010s), first commercial demonstrations (2020s), scaling to production (2030s). Key milestones to watch:

• 2026-2028: Varda, Space Forge, and others demonstrate regular production missions with return-to-Earth
• 2028-2030: Commercial space stations begin hosting dedicated manufacturing modules
• 2030-2035: First products manufactured in space reach commercial markets (ZBLAN fiber, specialty pharmaceuticals)
• 2035+: Starship-class heavy lift enables large-scale orbital factories, and lunar manufacturing begins using in-situ resources

The vision is ambitious but grounded in real physics and economics. Microgravity offers genuine manufacturing advantages that no terrestrial technology can replicate. As launch costs continue to fall and commercial platforms proliferate, the orbital factory may become as transformative for manufacturing as the semiconductor foundry was for computing.

Explore Space Manufacturing on SpaceNexus

SpaceNexus tracks the in-space manufacturing sector with company profiles, mission manifests, and technology readiness assessments. Our Space Manufacturing module covers every company building orbital factories, their technology approaches, funding status, and mission timelines.

Explore Space Manufacturing on SpaceNexus